New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 4, 2012
06:38 EDTJAZZCorrection: Jazz Pharmaceuticals initiates Erwinaze trial, says Brean Capital
Jazz announced initiated its new clinical trial for Erwinaze with will evaluate intravenous administration in patients with ALL as an alternative to intramuscular injection. Brean Murray maintains its estimates but believes there could be upside to its 2014 forecast. Shares are Buy rated with an $81 price target.
News For JAZZ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 14, 2015
12:49 EDTJAZZOn The Fly: Midday Wrap
Subscribe for More Information
12:09 EDTJAZZFlamel Technologies plunges after Jazz gets favorable patent ruling
Subscribe for More Information
January 12, 2015
13:21 EDTJAZZJazz Pharmaceuticals says 2015 will include top, bottom line growth
Subscribe for More Information
13:17 EDTJAZZJazz sees 2014 Erwinaze sales at upper end of range
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use